Revance Therapeutics, Inc. (RVNC) Social Stream
REVANCE THERAPEUTICS INC (RVNC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RVNC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 9 | $55 | $17 | $31.222 | $31.06 | 0.52% |
| 2021-11-11 | 9 | $55 | $17 | $30.888 | $31.06 | -0.55% |
| 2022-02-28 | 9 | $55 | $17 | $28.111 | $31.06 | -9.49% |
| 2022-05-24 | 9 | $55 | $17 | $28.333 | $31.06 | -8.78% |
| 2022-08-09 | 8 | $55 | $17 | $28.333 | $31.06 | -8.78% |
| 2022-08-11 | 8 | $55 | $17 | $28.888 | $31.06 | -6.99% |
| 2022-08-25 | 8 | $55 | $22 | $29.666 | $31.06 | -4.49% |
| 2022-09-09 | 10 | $65 | $24 | $34.222 | $31.06 | 10.18% |
| 2022-09-28 | 10 | $65 | $24 | $34.1 | $31.06 | 9.79% |
| 2022-10-11 | 10 | $65 | $24 | $33.454 | $31.06 | 7.71% |
| 2022-11-09 | 11 | $65 | $24 | $33.454 | $31.06 | 7.71% |
| 2022-12-06 | 11 | $65 | $24 | $33.636 | $31.06 | 8.29% |
| 2023-01-10 | 11 | $65 | $24 | $33.909 | $31.06 | 9.17% |
| 2023-01-23 | 11 | $65 | $24 | $34 | $31.06 | 9.47% |
| 2023-01-26 | 11 | $65 | $24 | $35.182 | $31.06 | 13.27% |
| 2023-01-31 | 11 | $65 | $24 | $36.182 | $31.06 | 16.49% |
| 2023-03-01 | 10 | $65 | $24 | $37.555 | $31.06 | 20.91% |
| 2023-03-15 | 10 | $65 | $24 | $38.222 | $31.06 | 23.06% |
| 2023-04-10 | 10 | $65 | $26 | $38.3 | $31.06 | 23.31% |
| 2023-04-19 | 11 | $65 | $26 | $38.3 | $31.06 | 23.31% |
| 2023-05-10 | 11 | $65.001 | $26 | $38.3 | $31.06 | 23.31% |
| 2023-05-11 | 11 | $65 | $26 | $40.4 | $31.06 | 30.07% |
The Trend in the Analyst Price Target
Over the past 32 weeks, RVNC's average price target has gone up $6.3.
Over the past 39 weeks, RVNC's average upside potential has been 26.32%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-22 | 10 | 65.000 | 24 | 34.100 | 25.56 | 33.41% |
| 2023-01-31 | 11 | 65.000 | 24 | 36.182 | 34.68 | 4.33% |
| 2023-04-12 | 11 | 65.000 | 26 | 38.300 | 30.52 | 25.49% |
| 2023-05-10 | 11 | 65.001 | 26 | 38.300 | 36.21 | 5.77% |
| 2023-05-11 | 11 | 65.000 | 26 | 40.400 | 35.72 | 13.1% |
RVNC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.45 | 8 | 1 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 151 days, RVNC's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, REVANCE THERAPEUTICS INC's variance in analysts' estimates is lower than -2052.04% of them.
- REVANCE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 329.32% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, REVANCE THERAPEUTICS INC's number of analysts covering the stock is higher than 1772.53% of them.
- RVNC has a greater average analyst price target than 1385.63% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to REVANCE THERAPEUTICS INC are TBPH, PRTA, and AGIO.
View All Top Stocks by Price Target
Is RVNC a Buy, Hold or Sell? See the POWR Ratings now!